Gangat N - Search Results

1

TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q).

Tefferi A, Fleti F, Chan O, Al Ali NH, Al-Kali A, Begna KH, Foran JM, Badar T, Khera N, Shah M, Hiwase D, Padron E, Sallman DA, Pardanani A, Arber DA, Orazi A, Reichard KK, He R, Ketterling RP, Gangat N, Komrokji R. Tefferi A, et al. Among authors: gangat n. Br J Haematol. 2024 Apr;204(4):1243-1248. doi: 10.1111/bjh.19247. Epub 2023 Dec 11. Br J Haematol. 2024. PMID: 38083865

2

Estrogen-based hormone therapy and thrombosis risk in women with essential thrombocythemia.

Gangat N, Wolanskyj AP, Schwager SM, Mesa RA, Tefferi A. Gangat N, et al. Cancer. 2006 Jun 1;106(11):2406-11. doi: 10.1002/cncr.21891. Cancer. 2006. PMID: 16628652 Free article.

3

Abdominal vein thrombosis in essential thrombocythemia: prevalence, clinical correlates, and prognostic implications.

Gangat N, Wolanskyj AP, Tefferi A. Gangat N, et al. Eur J Haematol. 2006 Oct;77(4):327-33. doi: 10.1111/j.1600-0609.2006.00715.x. Epub 2006 Jul 19. Eur J Haematol. 2006. PMID: 16856928

4

Risk stratification for survival and leukemic transformation in essential thrombocythemia: a single institutional study of 605 patients.

Gangat N, Wolanskyj AP, McClure RF, Li CY, Schwager S, Wu W, Tefferi A. Gangat N, et al. Leukemia. 2007 Feb;21(2):270-6. doi: 10.1038/sj.leu.2404500. Epub 2006 Dec 14. Leukemia. 2007. PMID: 17170720

5

Clinical correlates of JAK2V617F allele burden in essential thrombocythemia.

Kittur J, Knudson RA, Lasho TL, Finke CM, Gangat N, Wolanskyj AP, Li CY, Wu W, Ketterling RP, Pardanani A, Tefferi A. Kittur J, et al. Among authors: gangat n. Cancer. 2007 Jun 1;109(11):2279-84. doi: 10.1002/cncr.22663. Cancer. 2007. PMID: 17440984 Free article.

6

Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation.

Gangat N, Strand J, Li CY, Wu W, Pardanani A, Tefferi A. Gangat N, et al. Br J Haematol. 2007 Aug;138(3):354-8. doi: 10.1111/j.1365-2141.2007.06674.x. Br J Haematol. 2007. PMID: 17614822 Free article.

7

Cytogenetic studies at diagnosis in polycythemia vera: clinical and JAK2V617F allele burden correlates.

Gangat N, Strand J, Lasho TL, Finke CM, Knudson RA, Pardanani A, Li CY, Ketterling RP, Tefferi A. Gangat N, et al. Eur J Haematol. 2008 Mar;80(3):197-200. doi: 10.1111/j.1600-0609.2007.01003.x. Epub 2007 Dec 7. Eur J Haematol. 2008. PMID: 18081705

8

20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis.

Tefferi A, Gangat N, Wolanskyj AP, Schwager S, Pardanani A, Lasho TL, Mesa R, McClure RF, Li CY, Hanson CA. Tefferi A, et al. Among authors: gangat n. Eur J Haematol. 2008 May;80(5):386-90. doi: 10.1111/j.1600-0609.2008.01038.x. Epub 2008 Jan 23. Eur J Haematol. 2008. PMID: 18221390

9

Pruritus in polycythemia vera is associated with a lower risk of arterial thrombosis.

Gangat N, Strand JJ, Lasho TL, Li CY, Pardanani A, Tefferi A. Gangat N, et al. Am J Hematol. 2008 Jun;83(6):451-3. doi: 10.1002/ajh.21156. Am J Hematol. 2008. PMID: 18257107 Free article.

10

Pharmacotherapy of essential thrombocythemia.

Gangat N, Tefferi A. Gangat N, et al. Expert Opin Pharmacother. 2008 Jul;9(10):1679-85. doi: 10.1517/14656566.9.10.1679. Expert Opin Pharmacother. 2008. PMID: 18570601 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

370 results

Search Page

Filters